Free, public tool identifies COVID-19 “vaccine deserts” and helps public health leaders plan for how to equitably deliver the vaccine to the remaining U.S. population lacking access.
Ending the pandemic will require vaccinating everyone in every corner of the globe; it will require robust, adaptive systems that deliver with speed, scale, and equity as supply and demand shift over time.
Ariadne Labs’ Vaccine Delivery team is leveraging years of studying health care delivery systems to support health officials and decision makers with the tools and evidence needed to allocate, distribute, verify, and generate demand for COVID-19 vaccines.
The Vaccine Delivery team was among the first to raise the alarm about the dangers of vaccine nationalism. To assist leaders manage the initial scarcity of COVID-19 vaccines, the Vaccine Delivery team collaborated with the Center for Global Development to build an interactive web tool to generate predictions on the COVID-19 portfolio, in real-time, with up-to-date data.
As the US started to plan for vaccination, the team co-developed the Vaccine Allocation Planner with Surgo Ventures, which has been endorsed by the National Governors Association and has been used by the NYT, WaPo, WSJ, Univision, and others to visualize equitable vaccine delivery.
The Vaccine Delivery team is now working on new COVID-19 vaccine strategies to reach the people and populations not yet vaccinated in the US, including developing an implementation package for primary care providers to engage them in vaccination, aiding state and federal leaders in capturing best practices and figuring out how to track and improve vaccination delivery.
The team serves on the CONVINCE (COVID-19 New Vaccine Information, Communication, and Engagement) coalition to build the communication and demand generation infrastructure that will increase global vaccine confidence, works to inform media, and connects stakeholders around the globe to build bridges for vaccine delivery. The team is leveraging experience analysing best practices in delivery and its work in the US to help other countries learn and prepare for what’s ahead.
Resources
COVID-19 Vaccine Confidence Toolkit
Toolkit to support health care providers discuss the COVID-19 vaccine with hesitant patients.
COVID-19 Vaccine Predictor
The Center for Global Development and Ariadne Labs have created a tool to estimate vaccine success in a variety of scenarios.
Vaccine Allocation Planner for COVID-19
When COVID-19 vaccines become available in the US, states will need to allocate them to their highest priority populations. The Vaccine Allocation Planner for COVID-19 helps state and county decision prepare for...
Modelling the Manufacturing Process for COVID-19 Vaccines: Our Approach
The Center for Global Development and Ariadne Labs have teamed up to better understand how long it will take to develop a COVID-19 vaccine and manufacture it at scale.
Perspectives
News
MedPage Today: Patients Want COVID Shot From Their Primary Care Docs
Dr. Rebecca Weintraub on vaccine deserts and vaccination as a "family event."
Reuters: Not taking it: Remote West Texas COVID-19 vaccine hesitancy plain to see
Dr. Rebecca Weintraub on the key role of local physicians and leaders in reducing vaccine hesitancy.
News Channel 5: The future of COVID-19: What can we expect over the next six months?
Dr. Rebecca Weintraub on herd immunity and hospitalizations in the months to come.
New York Times: What Would It Take to Vaccinate the World Against Covid?
Dr. Rebecca Weintraub comments on the role of global leaders in the equitable distribution of COVID-19 vaccines.
Boston.com: Vaccine hesitancy could prolong the pandemic. A local team created a toolkit to overcome it.
Boston.com speaks to Dr. Evan Benjamin about the Vaccine Confidence Toolkit
Vox: The world could be doing much more to help India
Dr. Rebecca Weintraub on COVID-19 variants and vaccines in India.
WBUR: Combating COVID Vaccine Hesitancy May Be Next Battle For Mass.
Drs. Evan Benjamin and June-Ho Kim on strategies to combat vaccine hesitancy.
Barron’s: J&J’s Vaccine Pause Could Have Ripple Effects for the World
Dr. Rebecca Weintraub in Barron's on vaccine delivery with news of J&J vaccine pause.
Yahoo! News: America is about to hit a ‘vaccine wall’ as demand drops…
Benjy Renton's vaccine data maps featured in Yahoo! News
NPR: J&J Halt Isn’t Just a U.S. Problem
Dr. Rebecca Weintraub on the latest developments in vaccine delivery.
College Senior’s Efforts to Track COVID-19 Data Leads to Internship
It’s not often that a volunteer project on COVID-19 catches the attention of a national vaccine expert. But there was something exceptional about the consistently informative visualizations tweeted by Middlebury College...
NPR: Why It’s Easier to Get Coronavirus Vaccines in Some States
Dr. Rebecca Weintraub on NPR discussing the variation in access to vaccines state to state.
New York Times: Are We Much Too Timid in the Way We Fight Covid-19?
Dr. Atul Gawande's work referenced in latest opinion piece from Ezra Klein.
Harvard Gazette: Seeking ‘a leadership moment’ on global vaccination
In a Q&A, Dr. Rebecca Weintraub discusses America’s vaccination progress and the potential benefits of global vaccination.
WebMD: Many Grocery Workers Still Waiting for COVID-19 Shot
Dr. Rebecca Weintraub on states' vaccine guidelines and their impact on front-line essential workers.
Portland Press Herald: Vaccine hesitancy could threaten herd immunity
Dr. Evan Benjamin comments on addressing concerns that people may have about COVID-19 vaccines.
Al Jazeera: With a surplus looming, how should the US use excess vaccines?
Dr. Rebecca Weintraub remarks on the geopolitical implications of the U.S.'s plans for surplus vaccines.
Miami Herald: With Florida requiring doctor’s note for many, pace of COVID vaccination slows in Miami
Dr. Weintraub in the Miami Herald on the importance of an efficient vaccine delivery system.
Politics in Perspective: Vaccine Nationalism
Dr. Rebecca Weintraub explores vaccine nationalism on a podcast from the United Nations Association Youth Platform.
New York Times Interactive: Who’s Next in Your State’s Vaccine Line?
The latest New York Times Interactive on your place in the line for COVID-19 vaccines at the state level.
